112 related articles for article (PubMed ID: 26079962)
1. Statistical-based approach in potential diagnostic application of urinary nucleosides in urogenital tract cancer.
Daghir-Wojtkowiak E; Struck-Lewicka W; Waszczuk-Jankowska M; Markuszewski M; Kaliszan R; Markuszewski MJ
Biomark Med; 2015; 9(6):577-95. PubMed ID: 26079962
[TBL] [Abstract][Full Text] [Related]
2. Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis.
Szymańska E; Markuszewski MJ; Markuszewski M; Kaliszan R
J Pharm Biomed Anal; 2010 Dec; 53(5):1305-12. PubMed ID: 20719449
[TBL] [Abstract][Full Text] [Related]
3. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L
Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ
J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127
[TBL] [Abstract][Full Text] [Related]
5. Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.
Waszczuk-Jankowska M; Markuszewski MJ; Markuszewski M; Kaliszan R
Bioanalysis; 2012 Jun; 4(10):1185-94. PubMed ID: 22651562
[TBL] [Abstract][Full Text] [Related]
6. Advanced assessment of the endogenous hormone level as a potential biomarker of the urogenital tract cancer.
Konieczna L; Belka M; Baczek T; Ruszkowski M; Struck W; Markuszewski M; Kaliszan R; Markuszewski M
Comb Chem High Throughput Screen; 2013 Jul; 16(6):463-72. PubMed ID: 23410040
[TBL] [Abstract][Full Text] [Related]
7. Analysis of urinary methylated nucleosides of patients with coronary artery disease by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Li Y; Yu H; Zhao W; Xu X; Zhou J; Xu M; Gao W; Yuan G
Rapid Commun Mass Spectrom; 2014 Oct; 28(19):2054-8. PubMed ID: 25156594
[TBL] [Abstract][Full Text] [Related]
8. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic Heterogeneity of Urogenital Tract Cancers Analyzed by Complementary Chromatographic Techniques Coupled with Mass Spectrometry.
Yumba-Mpanga A; Struck-Lewicka W; Wawrzyniak R; Markuszewski M; Roslan M; Kaliszan R; Markuszewski MJ
Curr Med Chem; 2019; 26(1):216-231. PubMed ID: 28990506
[TBL] [Abstract][Full Text] [Related]
10. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer prognostic significance of some modified urinary nucleosides.
Sasco AJ; Rey F; Reynaud C; Bobin JY; Clavel M; Niveleau A
Cancer Lett; 1996 Nov; 108(2):157-62. PubMed ID: 8973589
[TBL] [Abstract][Full Text] [Related]
12. Steroid profiles as potential biomarkers in patients with urogenital tract cancer for diagnostic investigations analyzed by liquid chromatography coupled to mass spectrometry.
Konieczna L; Bączek T; Belka M; Fel A; Markuszewski M; Struck W; Markuszewski M; Kaliszan R
J Pharm Biomed Anal; 2013 Jan; 73():108-15. PubMed ID: 22475516
[TBL] [Abstract][Full Text] [Related]
13. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese.
Hsu WY; Chen CJ; Huang YC; Tsai FJ; Jeng LB; Lai CC
PLoS One; 2013; 8(12):e81701. PubMed ID: 24367489
[TBL] [Abstract][Full Text] [Related]
14. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
15. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of urinary nucleosides and creatinine assay by capillary electrophoresis with solid phase extraction.
Szymańska E; Markuszewski MJ; Bodzioch K; Kaliszan R
J Pharm Biomed Anal; 2007 Sep; 44(5):1118-26. PubMed ID: 17590562
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
Cho SH; Choi MH; Lee WY; Chung BC
Clin Biochem; 2009 Apr; 42(6):540-3. PubMed ID: 19186175
[TBL] [Abstract][Full Text] [Related]
18. Urinary nucleosides as biological markers for patients with colorectal cancer.
Zheng YF; Yang J; Zhao XJ; Feng B; Kong HW; Chen YJ; Lv S; Zheng MH; Xu GW
World J Gastroenterol; 2005 Jul; 11(25):3871-6. PubMed ID: 15991285
[TBL] [Abstract][Full Text] [Related]
19. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition.
Mao Y; Zhao X; Wang S; Cheng Y
Anal Chim Acta; 2007 Aug; 598(1):34-40. PubMed ID: 17693304
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of urinary nucleosides excretion of intestinal cancer patients by reversed-phase high performance liquid chromatography].
Zheng YF; Chen YJ; Pang T; Shi XZ; Kong HW; Lü S; Yang Q; Xu GW
Se Pu; 2002 Nov; 20(6):498-501. PubMed ID: 12682995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]